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Metabolic bone disease after gastrointestinal bypass proce-
dures is common and well documented. The degree of
malabsorption depends on the type of surgery, location
and the length of the digestive tract that is bypassed.
Abnormalities of calcium and vitamin D metabolism begin
shortly after these procedures, but clinical and biochemical
evidence may not be detected for many years or remain
undiagnosed. Routine monitoring of vitamin D and calcium
activity is advised in all patients after obesity surgery, and
supplementation with calcium and vitamin D is indicated to
prevent metabolic bone disease. Recommendations include
yearly screening of calcium, alkaline phosphatase, 25(OH)
vitamin D and parathyroid hormone (PTH). A rise in the levels
of alkaline phosphatase or PTH indicates the need to increase
supplementation.
Case report
A 41-year-old, premenopausal obese female presented to the
emergency room with severe pain over her left hip 1 week
after a ground level fall. She was capable of bearing full
weight on the extremity. However, this provoked further pain
and muscle spasm.
Her past history was significant for morbid obesity (max
weight of 550 pounds) for which she underwent a Roux-en-Y* Corresponding author at: 4201 Harwin Circle, Apt 1203,
Glen Allen, VA 23060, USA. Tel.: +1 786 266 5072.
E-mail address: vmounasa@yahoo.com (V. Mounasamy).
1572-3461# 2007 Elsevier Ltd.
doi:10.1016/j.injury.2007.07.031
Open access under the Elsevier OA license. gastric bypass 10 years earlier. Following this procedure, she
had briefly taken antacids (TUMS1), but otherwise, she had
not taken any supplementation for nearly 8 years. Two years
prior to her fall, the patient was diagnosed with osteomalacia
when she presented with worsening bone and joint pain.
Calcium, vitamin D and vitamin B12 supplementation were
advised but neglected. Lastly, her past medical history was
remarkable for a lateral collateral ligament injury in her left
knee at 17 years of age which had required surgical recon-
struction. A common peroneal nerve palsy accompanied this
injury and persisted to date.
Physical examination revealed mild tenderness over the
left proximal femur and greater trochanter. She had sym-
metric, unrestricted range of motion of the hips. There was
no limb length discrepancy. A long, healed incision was noted
over lateral aspect of the left knee. She had a foot drop in the
left lower leg with diminished sensation over the dorsum of
the foot. Dorsalis pedis and posterior tibial pulses were
palpable. Her current body mass index was calculated to
be 45.8.
Plain radiographs revealed a cortical lucency extending
half way across the femoral shaft just inferior to the lesser
trochanter consistent with an insufficiency fracture. The
lateral cortex remained intact (Figs. 1 and 2). A comparison
with radiographs dated 2 years prior revealed definite pro-
gression of a previously noted medial cortical lucency at the
same location. A CT scan confirmed an incomplete fracture
immediately distal to the lesser trochanter of the femur with
heterotopic ossification in the iliopsoas tendon near the
site of insertion (Figs. 3 and 4). Subsequently, the patient
was admitted for biochemical evaluation and prophylactic
stabilisation of the impending fracture.
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Figure 3 Coronal CTscan images reveal an incomplete fracture
immediately distal to the lesser trochanter of the left femur with
heterotrophic ossification of the left psoas tendon near its
insertion.
Figure 1 AP radiograph showing the fracture showing the
insufficiency fracture involving the medial cortex of the femur
at the level of lesser trochanter.Given the patient’s history of gastric bypass and concerns
related to associated malabsorption, a comprehensive bio-
chemical evaluation was conducted. Significant findings
included: SFig
ins
cherum calcium 6.7 mg/dl; 25(OH) vitamin D 7.0 ng/ml;
 Alkaline phosphatase 164 units/l;
 PTH 696.3 pg/ml.
Additional laboratory data included low haemoglobin
(9.8 gm/dl) and serum magnesium (1.7 mg/l) levels. Lowure 2 Lateral radiograph showing the fracture showing the
ufficiency fracture of the femur at the level of lesser tro-
anter.serum B12 levels (136 pg/ml) and red cell indices confirmed
vitamin B12 deficiencywithmicrocytic anaemia. Her sedimen-
tation rate was 23 mmm/h with a C reactive protein level of
0.3 mg/dl. Her serum proteins were in the normal range, with
an A/G ratio of 1.6. Serum and urinary electrophoresis were
normal. Serum phosphorus measured 3.0 mg/dl. Lastly, an
elevated ratio of urinary N-telopeptide type I collagen/crea-
tinine (NTX = 168 nmol/mmol creatinine) reflected significantFigure 4 Saggital CT image showing an incomplete fracture
immediately at the level of the lesser trochanter and excessive
abdominal pannus.
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Figure 5 Postoperative radiographs at 4 weeks with implant
(ACE DePuy, ATN) in situ.bone reabsorption given a normal mean ratio of 35 in pre-
menopausalwomen. Analysis of this data suggested adiagnosis
of insufficiency fracture due to secondary hyperparathyroid-
ism associated with malabsorption of calcium and vitamin D
due to gastrointestinal bypass.
The patient elected for intramedullary nailing of the
femur to prevent completion of the fracture. Evaluating
the fracture with Mirels criteria, the fracture scored posi-
tively on 9 of 12 criteria indicating a 33% risk of fracture. Her
postoperative course was uncomplicated. She was initially
mobilised partial weight bearing with the use of a walker and
a foot drop splint. On consultation with the bariatric surgery
and endocrinology services, the patient was started on nutri-
tional supplementation therapy (1200 mg of calcium and
5000 IU of vitamin D/day) and discharged home.
At follow up, 4 weeks after intramedullary nailing, the
patient reported significant pain relief. She was capable of
full weight bearing without the apprehension or instability
which she had noted after the fall. She had full range of
motion in her left hip with persistence of the previously noted
foot drop. Radiographs confirmed appropriate position of the
intramedullary implant bridging the recognised insufficiency
fracture. There had been no further progression of the
fracture (Fig. 5).
Discussion
Bariatric surgery for morbid obesity is becoming increasingly
popular. Two common procedures in use today are the ver-
tical banded gastroplasty and Roux-en-Y gastric bypass.
Intestinal malabsorption after gastrointestinal bypass sur-
gery for obesity is well documented in literature. The degreeofmalabsorption depends on the type of surgery, location and
the length of the digestive tract that is bypassed. Abnorm-
alities of calcium and vitamin D metabolism begin shortly
after these procedures, but clinical and biochemical evi-
dence may not be detected for many years or remain undiag-
nosed.5 Gastric bypass patients can develop calcium and
vitamin D malabsorption in addition to protein, fat and other
vitamin or mineral deficiencies.
Calcium is absorbed in the duodenum and the proximal
jejunum. Vitamin D is absorbed from the diet in the small
intestine as well. Its absorption can be altered by multiple
factors that include steatorrhea, alteration in bile acid
metabolism, intestinal bypass and the presence of fat. Hypo-
calcaemia per se can lead to steatorrhea due to reduced
secretion of pancreatic enzymes thus enhancing malabsorp-
tion. Lastly, decreased dietary intake of vitamin D and
calcium rich foods in this setting can lead to altered calcium
and vitamin D homeostasis as well.
Secondary hyperparathyroidism caused by hypocalcaemia
or vitamin D deficiency has been reported in association with
gastric bypass surgery.8 In the normal state, low levels of
calcium promote increased PTH activity with subsequent
mobilisation of calcium from bone stores and enhanced
intestinal absorption and urinary reabsorption. PTH and
hypocalcaemia stimulate conversion of inactive 25(OH) vita-
min D to active 1,25(OH) vitamin D which accentuates this
process. 1,25(OH)D promotes calcium absorption from the
small intestine and osteoclastic bone reabsorption. Similarly,
PTH increases calcium release from bone via osteoclastic
activity in addition to renal tubular calcium reabsorption.
In the abnormal state, persistent hypocalcaemia induces
the over production of PTH. Excessive bone reabsorption
progresses and osteomalacia ensues. Normal trabecular bone
is replaced by unmineralised osteoid. Areas of unmineralised
osteoid additionally appear within the Haversian system of
cortical bone. Quantitative histomorphometry of bone biopsy
specimens reveal widened osteoid seams confirmatory of
osteomalacia.
Vitamin D deficiency is defined as a 25(OH) vitamin D
concentration of less than or equal to 8 ng/ml. Active vitamin
D is essential for active intestinal absorption of calcium.
Dietary deficiency or malabsorption of vitamin D can subse-
quently further contribute to hypocalcaemia, osteomalacia
and the cycle promoting a state of secondary hyperparathyr-
oidism.
Metabolic bone disease is often misdiagnosed or under-
diagnosed.1 In many cases, elevated alkaline phosphatase or
elevated PTH may be the only early signs of metabolic bone
disease. Routine monitoring of vitamin D and calcium meta-
bolism is advised in all patients after obesity surgery. Yearly
screening typically includes evaluation of calcium, alkaline
phosphatase, 25(OH) vitamin D and PTH. Inadequate supple-
mentation is suggested by a rise in PTH or alkaline phospha-
tase, and more aggressive therapy is indicated.
Carlin et al. in their study observed that a majority of
morbidly obese patients have vitamin D depletion and sec-
ondary hyperparathyroidism, preoperatively and advised
preoperative evaluation of vitamin D nutritional status.2
Youssef et al. reported a high incidence of elevated PTH
levels after gastric bypass surgery in morbidly obese women
with BMI > 50.9 They concluded in their study that African-
American women and women older than 45 years of age were
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suggested, aggressive supplementation with calcium citrate
and vitamin D in that specific group. Johnson et al. reported a
higher incidence of secondary hyper-parathyroidism in short-
limb gastric bypass patients, indicating selective calcium
malabsorption.6 They advised calcium and vitamin D supple-
mentation to prevent deficiencies and the sequelae of sec-
ondary hyperparathyroidism.
Biochemical markers of bone turnover provide useful
information in the diagnosis and management of metabolic
bone disease. Recent advances include evaluation of sensi-
tive markers to access bone formation (osteocalcin, bone
alkaline phosphatase and N-terminal propeptide of type I
procollagen). Blood or urinary immunoassays of pyridinoline,
deoxy-pyridinoline and terminal telopeptides of type I col-
lagen can be useful in the assessment of bone resorption.
Urinary N-telopeptide of type 1 collagen is determined
from a fasting, secondmorning-void urine. The N-telopeptide
type I collagen/creatine ratio (termed NTX) may then be
compared to standard scales developed for men, premeno-
pausal and postmenopausal women. Elevated NTX ratios have
been correlated with a probability of a decrease in bone
mineral density. A high baseline NTX (>67 nM/mM Crt) indi-
cates a 17.3 times higher risk of decreased bone mineral
density.3 This particular patient had a NTX ratio of 168 nM/
mM creatinine.
Similar to the use of NTX in predicting the loss of bone
density, the NTX value has been demonstrated as a useful tool
in monitoring anti-resorptive therapy. The probability that
treatment is effective after 3 months is increased when the
NTX value is less than 38 nM/mM creatinine or a 30% decrease
is noted. Standard bone mineral density measurements cus-
tomarily require at least 2 years of therapy in order to define
significant improvement. Because treatment with anti-
resorptive drugs is followed by a rapid response of bone
markers levels (generally 3 months for the markers of resorp-
tion and 6 months for those of osteo-formation), assessment
of these markers may become of increasing clinical impor-
tance in the management of metabolic bone disease.
Our patient presented with an insufficiency fracture of the
left subtrochanteric region 10 years after gastric bypass
surgery requiring operative stabilisation. Laboratory findingsof microcytic anaemia, B12 deficiency and metabolic bone
disease inclusive of hypocalcaemia, vitamin D deficiency and
elevated PTH and alkaline phosphatase were consistent with
amalabsorption syndrome following gastric bypass surgery. In
view of significant obesity and a 33% risk of fracture as per
Mirels criteria, we recommended operative stabilisation to
prevent completion of the impending fracture.7 To our
knowledge, we are not aware of any report of a similar type
but severe metabolic bone disease after obesity surgery has
been reported.4 Accordingly, routine supplementation and
monitoring of calcium and vitamin D metabolism are strongly
advocated following these procedures.
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